Yüklüyor......
Rationale and design of the allogeneiC human mesenchymal stem cells (hMSC) in patients with aging fRAilTy via intravenoUS delivery (CRATUS) study: A phase I/II, randomized, blinded and placebo controlled trial to evaluate the safety and potential efficacy of allogeneic human mesenchymal stem cell infusion in patients with aging frailty
Frailty is a syndrome associated with reduced physiological reserves that increases an individual's vulnerability for developing increased morbidity and/or mortality. While most clinical trials have focused on exercise, nutrition, pharmacologic agents, or a multifactorial approach for the preve...
Kaydedildi:
Yayımlandı: | Oncotarget |
---|---|
Asıl Yazarlar: | , , , , , , , , , , , , |
Materyal Türü: | Artigo |
Dil: | Inglês |
Baskı/Yayın Bilgisi: |
Impact Journals LLC
2016
|
Konular: | |
Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4914257/ https://ncbi.nlm.nih.gov/pubmed/26933813 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.7727 |
Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|